Skip Navigation

Find a Research Lab

Research Lab Results for cancer

Displaying 1 to 50 of 96 results
Results per page:
  • Ami Shah Lab

    Lab Website
    Principal Investigator:
    Ami Shah, M.D.
    Medicine

    Researchers in the Ami Shah Lab study scleroderma and Raynaud’s phenomenon. We examine the rela...tionship between cancer and scleroderma, with a focus on how and if cancer causes scleroderma to develop in some patients. We are currently conducting clinical research to study ways to detect cardiopulmonary complications in patients with scleroderma, biological and imaging markers of Raynaud’s phenomenon, and drugs that improve aspects of scleroderma. view more

    Research Areas: Raynaud's phenomenon, cancer, scleroderma, drugs, cardiovascular diseases
  • Amit Pahwa Lab

    Principal Investigator:
    Amit Pahwa, M.D.
    Medicine

    The Amit Pahwa Lab conducts research on a variety of topics within internal medicine. Our most ...recent studies have explored misanalysis of urinalysis results, urinary fractional excretion indices in the evaluation of acute kidney injury and nocturnal enuresis as a risk factor for falls in older women. We also investigate cancer diagnostics and treatments. In this area, our recent research has included studying cutaneous shave biopsies for diagnosing primary colonic adenocarcinoma as well as growth inhibition and apoptosis in human brain tumor cell lines using selenium. view more

    Research Areas: acute kidney injury, cancer, internal medicine, urology
  • Andrew Feinberg Laboratory

    Lab Website
    Principal Investigator:
    Andrew Feinberg, M.D., M.P.H.
    Medicine

    The Feinberg Laboratory studies the epigenetic basis of normal development and disease, includi...ng cancer, aging and neuropsychiatric illness. Early work from our group involved the discovery of altered DNA methylation in cancer as well as common epigenetic (methylation and imprinting) variants in the population that may be responsible for a significant population-attributable risk of cancer.

    Over the last few years, we have pioneered the field of epigenomics (i.e., epigenetics at a genome-scale level), founding the first NIH-supported NIH epigenome center in the country and developing many novel tools for molecular and statistical analysis. Current research examines the mechanisms of epigenetic modification, the epigenetic basis of cancer, the invention of new molecular, statistical, and epidemiological tools for genome-scale epigenetics and the epigenetic basis of neuropsychiatric disease, including schizophrenia and autism.
    view more

    Research Areas: autism, cancer, epigenetics, schizophrenia, human development, aging, DNA, genomics, neuropsychiatric disease
  • Andrew Laboratory: Center for Cell Dynamics

    Lab Website
    Principal Investigator:
    Deborah Andrew, Ph.D., M.S.
    Cell Biology

    Researchers in the Center for Cell Dynamics study spatially and temporally regulated molecular ...events in living cells, tissues and organisms. The team develops and applies innovative biosensors and imaging techniques to monitor dozens of critical signaling pathways in real time. The new tools help them investigate the fundamental cellular behaviors that underlie embryonic development, wound healing, cancer progression, and functions of the immune and nervous systems. view more

    Research Areas: immunology, cancer, epithelial tube, nervous system, molecular biology
  • Anne Marie Lennon Lab

    The Lennon Lab does clinical and translational research on endoscopic ultrasound, esophageal ca...ncer, gastric cancer, gastroenterology, pancreatic cancer, pancreatic cysts, therapeutic endoscopy, Von Hippel-Lindau (VHL)

    view more

    Research Areas: Von Hippel-Lindau (VHL), gastroenterology, pancreatic cancer, Endoscopic Ultrasound, Esophageal Cancer, Pancreatic Cysts, Therapeutic Endoscopy, Gastric Cancer
  • Antony Rosen Lab

    Principal Investigator:
    Antony Rosen, M.B.Ch.B., M.S.
    Medicine

    Research in the Antony Rosen Lab investigates the mechanisms shared by the autoimmune rheumatic... diseases such as lupus, myositis, rheumatoid arthritis, scleroderma and SjogrenÕs syndrome. We focus on the fate of autoantigens in target cells during various circumstances, such as viral infection, relevant immune effector pathways and exposure to ultraviolet radiation. Our recent research has sought to define the traits of autoantibodies that enable them to induce cellular or molecular dysfunction. We also work to better understand the mechanisms that form the striking connections between autoimmunity and cancer. view more

    Research Areas: myositis, lupus, rheumatology, Sjogren's syndrome, scleroderma, autoimmune rheumatic diseases, rheumatoid arthritis
  • Brain Cancer Biology and Therapy Lab

    Lab Website
    Principal Investigator:
    Gregory Riggins, M.D., Ph.D.
    Neurosurgery

    The goal of the Johns Hopkins Brain Cancer Biology and Therapy Laboratory is to locate the gene...tic and genomic changes that lead to brain cancer. These molecular changes are evaluated for their potential as therapeutic targets and are often mutated genes, or genes that are over-expressed during the development of a brain cancer. The brain cancers that the Riggins Laboratory studies are medulloblastomas and glioblastomas. Medulloblastomas are the most common malignant brain tumor for children and glioblastomas are the most common malignant brain tumor for adults. Both tumors are difficult to treat, and new therapies are urgently needed for these cancers. Our laboratory uses large-scale genomic approaches to locate and analyze the genes that are mutated during brain cancer development. The technologies we now employ are capable of searching nearly all of a cancer genome for molecular alterations that can lead to cancer. The new molecular targets for cancer therapy are first located by large scale gene expression analysis, whole-genome scans for altered gene copy number and high throughput sequence analysis of cancer genomes. The alterations we find are then studied in-depth to determine how they contribute to the development of cancer, whether it is promoting tumor growth, enhancing the ability for the cancer to invade into normal tissue, or preventing the various fail-safe mechanisms programmed into our cells. view more

    Research Areas: brain cancer
  • Brain Tumor Cancer Genetics Lab

    Lab Website

    The lab explores the genetic underpinnings that drive the pathogenesis of a variety of primary ...central nervous system neoplasms. We are interested in exploiting genetic changes for both diagnostic and therapeutic purposes. Our lab is currently working on understanding the extreme responders and extreme clinical phenotypes of brain and spinal cord tumors to identify factors that may modulate responses to therapy. view more

    Research Areas: brain tumor genetics, brain tumor
  • Brennen Lab

    Principal Investigator:
    William Brennen, Ph.D.
    Oncology

    The Brennen laboratory takes a rigorous, multi-disciplinary, team-based approach towards develo...ping innovative therapeutic and prognostic strategies for prostate cancer with an emphasis on exploiting vulnerabilities within the tumor microenvironment towards this goal. To accomplish this goal, we are strategically pursuing novel therapeutic platforms, including stromal-targeted prodrugs, protoxins, and radiolabeled antibodies, in addition to cell-based therapy and drug delivery; all of which are designed to reduce toxicity to peripheral non-target tissue (i.e. side effects) while maximizing anti-tumor efficacy (i.e. therapeutic benefit). Currently, many of these strategies are focused on overcoming stromal barriers to anti-tumor immune responses such that men suffering from prostate cancer can share in the immense, revolutionary power of immunotherapy that is transforming care for many with advanced disease in other tumor types previously thought to be unmanageable using conventional approaches. Unfortunately, prostate cancer has largely proven refractory to these powerful approaches thus far and requires novel mono- or combinatorial treatment strategies to unleash the full potential of the immune system and generate personalized anti-tumor responses with the capability of producing long-term durable responses or even cures in these men. view more

    Research Areas: prostate cancer, prodrugs, cell-based therapy, tumor microenvironment
  • Brindusa Truta Lab

    Principal Investigator:
    Brindusa Truta, M.D., M.A.S.
    Medicine

    The Brindusa Truta Lab studies inflammatory bowel diseases, specifically Crohn’s disease and ul...cerative colitis. Recent studies defined factors associated with the development of Crohn's disease after ileal pouch anal anastomosis; determined the value of histology in identifying Lynch syndrome in early-onset of colorectal cancer patients; and compared the phenotype and genotype in adenomatous polyposis patients with and without a family history. view more

    Research Areas: inflammatory bowel disease, Crohn’s disease, ulcerative colitis
  • Center for Nanomedicine

    Lab Website
    Principal Investigator:
    Justin Hanes, Ph.D.
    Ophthalmology

    The Center for Nanomedicine engineers drug and gene delivery technologies that have significant... implications for the prevention, treatment and cure of many major diseases facing the world today. Specifically, we are focusing on the eye, central nervous system, respiratory system, women's health, gastrointestinal system, cancer, and inflammation.

    We are a unique translational nanotechnology effort located that brings together engineers, scientists and clinicians working under one roof on translation of novel drug and gene delivery technologies
    view more

    Research Areas: central nervous system, respiratory system, nanotechnology, cancer, drugs, women's health, inflammation, eye, gastrointestinal
  • Cervical Cancer Research Lab

    Lab Website

    Johns Hopkins is a member of the Specialized Program of Research Excellence (SPORE) in Cervical... Cancer. With a $11.5 million grant from the National Cancer Institute, we are conducting lab, translational and clinical studies to prevent and treat cervical cancers. Previous studies have identified connections between immune system genes and HPV16. Current projects include the development of next-generation HPV vaccines to control HPV-associated precursor lesions and invasive cancer. Our dedicated researchers are working to extend the techniques used in HPV vaccine development to the creation of vaccines targeting other cancers with defined tumor antigens. view more

    Research Areas: HPV vaccines, cervical cancer, HPV
  • Cervical Dysplasia Research Lab

    Lab Website

    We are interested in how immune responses occur in the cervix. The focus of our translational ...research is on developing immune therapies for disease caused by human papillomavirus (HPV). HPV infection causes more cancers than any other virus in the world. Cervical cancer is the most common cancer caused by HPV, and although we have known how to screen for it for over half a century, it remains the second most common cause of cancer death in women. Although the preventive vaccines are a public health milestone, they prevent HPV infections, but are not designed to make immune responses to treat HPV. We are testing different strategies to make immune responses that could treat HPV disease. Our dedicated researchers are working to extend the techniques used in HPV vaccine development to the creation of vaccines targeting other cancers with defined tumor antigens. view more

    Research Areas: cervical cancer, HPV, cancer vaccines
  • Christine Durand Lab

    Principal Investigator:
    Christine Durand, M.D.
    Medicine

    Dr. Christine Durand, assistant professor of medicine and oncology and member of the Johns Hopk...ins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation.

    Dr. Durand is supported by multiple grants:

    • R01 from the National Institute of Allergy and Infectious Diseases (NIAID) to study HIV-to-HIV organ transplantation in the US.
    • K23 from the National Cancer Institute (NCI) to study antiretroviral therapy during bone marrow transplant in HIV-1 infection.
    • U01 from the NIAID to study HIV-to-HIV deceased donor kidney transplantation.
    U01 from the NIAID to study HIV-to-HIV deceased donor liver transplantation.
    view more

    Research Areas: Bone Marrow Transplantation, transplants, infectious disease, AIDS, HIV, Solid Organ Transplantation, hepatitis C
  • Claire Snyder Lab

    Principal Investigator:
    Claire Snyder, Ph.D., M.H.S.
    Medicine

    Researchers in the Claire Snyder Lab study the quality of cancer care, with a special focus on ...two areas: the quality of life for cancer patients undergoing treatment and the coordination of care between cancer specialists and primary care providers. As part of our quality-of-life research, we're investigating the use of patient-reported outcome questionnaires in routine oncology practice as well as developing a website for collecting the questionnaires and linking them with the electronic medical record. As part of our cancer-survivorship research, we've conducted large database studies to identify the physician specialties involved in the care of cancer survivors and to determine how that relates to survivors receiving recommended follow-up care. We're also working with investigators in the Sydney Kimmel Comprehensive Cancer Center to develop care strategies for breast cancer survivors. view more

    Research Areas: breast cancer, cancer survivors, cancer, quality of life, care coordination
  • Constance Monitto Lab

    Lab Website

    The Constance Monitto Lab conducts clinical research on pediatric pain management as well as ba...sic science studies on chemotherapy resistance. In our pediatric pain management research, we work to assess the impact of low-dose opioid antagonism on opioid-related side effects, such as nausea and vomiting. We also analyze data on current methods of pediatric pain management in the United States. In addition, our team uses basic science studies to assess the success of epigenetic gene regulation on the development of resistance to chemotherapeutic agents in cancer. view more

    Research Areas: chemotherapy, opioids, epigenetics, gene regulation, pain, pediatrics
  • Craig Pollack Lab

    Principal Investigator:
    Craig Pollack, M.D., M.H.S.
    Medicine

    Research in the Craig Pollack Lab focuses on cancer prevention and control, particularly prosta...te cancer. Our work aims to understand how the organization environment of health care affects the type and quality of care that patients receive. Other work investigates the broader social context of health and health care— specifically housing, financial hardship and socioeconomic status. view more

    Research Areas: sociodemographics, prostate, cancer, quality of care
  • Cynthia Sears Laboratory

    Principal Investigator:
    Cynthia Sears, M.D.
    Medicine
    Oncology

    Work in the Cynthia Sears Laboratory focuses on the bacterial contributions to the development ...of human colon cancer and the impact of the microbiome on other cancers and the therapy of cancer. The current work involves mouse and human studies to define how enterotoxigenic Bacteroides fragilis, pks+ Escherichia coli, Fusobacterium nucleatum, biofilms and the colonic microbiota induce chronic colonic inflammation and colon cancer. Prospective human studies of the microbiome and biofilms in screening colonoscopy are in progress as are studies to determine if and how the microbiome impacts the response of individuals with cancer to immunotherapy and other cancer therapies.

    view more

    Research Areas: epidemiology, AIDS, microbiome, colon cancer, enterotoxigenic Bacteroides fragilis, chronic colonic inflammation
  • David Cooper Lab

    Principal Investigator:
    David Cooper, M.D.
    Medicine

    Research in the David S. Cooper Lab focuses primarily on hyperthyroidism and thyroid cancer. To...pics of recent published studies include the NTCTCS staging systems for differentiated thyroid cancer, radioiodine remnant ablation in low-risk differentiated thyroid cancer, and the link between race/ethnicity and the prevalence of thyrotoxicosis in young Americans. view more

    Research Areas: neoplasms, hyperthyroidism, cancer, thyroidectomy, thyroid, Graves’ disease, hypothyroidism
  • Devreotes Laboratory

    Lab Website
    Principal Investigator:
    Peter Devreotes, Ph.D.
    Cell Biology

    The Devreotes Laboratory is engaged in genetic analysis of chemotaxis in eukaryotic cells. Our ...long-term goal is a complete description of the network controlling chemotactic behavior. We are analyzing combinations of deficiencies to understand interactions among network components and carrying out additional genetic screens to identify new pathways involved in chemotaxis. A comprehensive understanding of this fascinating process should lead to control of pathological conditions such as inflammation and cancer metastasis. view more

    Research Areas: biochemistry, cell biology, chemotaxis, cancer, genomics, inflammation
  • Dmitri Artemov Lab

    The Artemov lab is within the Division of Cancer Imaging Research in the Department of Radiolog...y and Radiological Science. The lab focuses on 1) Use of advanced dynamic contrast enhanced-MRI and activated dual-contrast MRI to perform image-guided combination therapy of triple negative breast cancer and to assess therapeutic response. 2) Development of noninvasive MR markers of cell viability based on a dual-contrast technique that enables simultaneous tracking and monitoring of viability of transplanted stems cells in vivo. 3) Development of Tc-99m and Ga-68 angiogenic SPECT/PET tracers to image expression of VEGF receptors that are involved in tumor angiogenesis and can be important therapeutic targets. 4) Development of the concept of “click therapy” that combines advantages of multi-component targeting, bio-orthogonal conjugation and image guidance and preclinical validation in breast and prostate cancer models. view more

    Research Areas: VEGF receptors image expression, SPECT/PET tracers, tracking stem cells in vivo, triple-negative breast cancer, image-guided combination therapy, MRI, noninvasive MR markers, cancer imaging
  • Douglas Ball Lab

    Principal Investigator:
    Douglas Ball, M.D.
    Medicine

    The Douglas Ball Lab conducts clinical trials and pre-clinical laboratory studies of thyroid ca...ncer. Our clinical trials, performed in collaboration with research staff in the upper aero-digestive group in the Sidney Kimmel Comprehensive Cancer Center, have included protocols for advanced radioiodine-refractory differentiated thyroid cancer and medullary thyroid cancer. Our pre-clinical research, conducted with Dr. Nelkin, Dr. Agrawal and other Kimmel Cancer Center researchers, includes pathogenesis and mechanisms of treatment resistance in medullary thyroid cancer, and pathogenesis and immune-directed therapy of anaplastic thyroid cancer. view more

    Research Areas: thyroid cancer, medullary thyroid cancer, cancer, anaplastic thyroid cancer
  • Drew Pardoll Lab

    The Pardoll Lab focuses on the regulation of antigen-specific T cell responses and studies appr...oaches to modify these responses for immunotherapy. Pardoll has a particular interest in cancer immunology and his lab’s studies on basic immunologic mechanisms have led to the development and design of a number of cancer vaccines and discovery of key checkpoint ligands and receptors, such as PD-L2, LAG-3 and neuritin, many of which are being targeted clinically.

    Our primary pursuits are discovering and elucidating new molecules that regulate immune responses, investigating the biology of regulatory T cells, and better understanding the specific biochemical signatures that allow a patient’s T cells to selectively target cancer cells.
    view more

    Research Areas: tumor antigens, cancer, immunotherapy, regulatory T cells, T cells
  • Drug Discovery Group

    Lab Website
    Principal Investigator:
    Barbara Slusher, Ph.D., M.A.S.
    Oncology

    Barbara Slusher, M.A.S., Ph.D., leads a 20-member veteran drug discovery team of medicinal chem...ists, assay developers, pharmacologists, toxicologists and pharmacokinetic/drug metabolism experts, who identify novel drug targets arising from JHU faculty’s research and translate them into new, small molecule drug therapies.

    Her team collaborates extensively with faculty at the Bloomberg~Kimmel Institute for Cancer Immunotherapy and leads the BKI immunotherapy drug discovery core, aimed at developing new immune-targeting drug therapies for laboratory and clinical testing at Johns Hopkins.
    view more

    Research Areas: glutamine antagonist, drug discovery, cancer, immunotherapy, cancer metabolism
  • Early Detection of Pancreatic Cancer Laboratory

    The goal of the lab's research is to identify molecular abnormalities that can improve the outc...ome of patients with pancreatic cancer and those at risk of developing this disease. Much of our work is focused on translational research evaluating markers and marker technologies that can help screen patients with an increased risk of developing pancreatic cancer.

    Thus, marker efforts have been focused mostly on identifying markers of advanced precancerous neoplasia (PanINs and IPMNs) that could improve our ability to effectively screen patients at risk of developing pancreatic cancer. We lead or participate in a number of clinical research protocols involved in the screening and early detection of pancreatic neoplasia including the CAPS clinical trials. We maintain a large repository of specimens from cases and controls with and without pancreatic disease and use this repository to investigate candidate markers of pancreatic cancer for their utility to predict pancreatic cancer risk.

    In addition, we have been working to identify familial pancreatic cancer susceptibility genes and identified BRCA2 as a pancreatic cancer susceptibility gene in 1996. We participate in the PACGENE consortium and the familial pancreatic cancer sequencing initiative. My lab also investigates pancreatic cancer genetics, epigenetics, molecular pathology, tumor stromal interactions and functional analysis of candidate genes and miRNAs. Dr. Goggins is the principal investigator of a phase I/II clinical trial evaluating the Parp inhibitor, olaparib along with irinotecan and cisplatin for patients with pancreatic cancer.
    view more

    Research Areas: pancreatic cancer
  • Eberhart, Rodriguez and Raabe Lab

    Lab Website
    Principal Investigator:
    Charles Eberhart, M.D., Ph.D.
    Pathology

    Utilizing a combination of tissue-based, cell-based, and molecular approaches, our research goa...ls focus on abnormal telomere biology as it relates to cancer initiation and tumor progression, with a particular interest in the Alternative Lengthening of Telomeres (ALT) phenotype. In addition, our laboratories focus on cancer biomarker discovery and validation with the ultimate aim to utilize these novel tissue-based biomarkers to improve individualized prevention, detection, and treatment strategies. view more

    Research Areas: cancer therapies, preventing cancer metastasis, cancer, cancer biomarkers
  • Eberhart, Rodriguez and Raabe Lab

    Lab Website
    Principal Investigator:
    Charles Eberhart, M.D., Ph.D.
    Pathology

    Utilizing a combination of tissue-based, cell-based, and molecular approaches, our research goa...ls focus on abnormal telomere biology as it relates to cancer initiation and tumor progression, with a particular interest in the Alternative Lengthening of Telomeres (ALT) phenotype. In addition, our laboratories focus on cancer biomarker discovery and validation with the ultimate aim to utilize these novel tissue-based biomarkers to improve individualized prevention, detection, and treatment strategies.
    view more

    Research Areas: stem cells, eye tumor, tumor cell metastasis, brain tumor
  • Elham Afghani Lab

    Principal Investigator:
    Elham Afghani, M.D., M.P.H.
    Medicine

    The Elham Afghani Lab performs clinical research on pancreatic auto islet transplants, pancreat...ic cancer, pancreatic cysts, and pancreatitis. view more

    Research Areas: pancreatic cancer, Pancreatic Auto Islet Transplant, pancreatitis, Pancreatic Cysts
  • Elizabeth M. Jaffee, M.D.

    Lab Website
    Principal Investigator:
    Elizabeth Jaffee, M.D.
    Oncology

    Current projects include:

    The evaluation of mechanisms of immune tolerance to cancer in m...ouse models of breast and pancreatic cancer. We have characterized the HER-2/neu transgenic mouse model of spontaneous mammary tumors.
    This model demonstrates immune tolerance to the HER-2/neu gene product. This model is being used to better understand the mechanisms of tolerance to tumor. In addition, this model is being used to develop vaccine strategies that can overcome this tolerance and induce immunity potent enough to prevent and treat naturally developing tumors. More recently, we are using a genetic model of pancreatic cancer developed to understand the early inflammatory changes that promote cancer development.

    The identification of human tumor antigens recognized by T cells. We are using a novel functional genetic approach developed in our laboratory. Human tumor specific T cells from vaccinated patients are used to identify immune relevant antigens that are chosen based on an initial genomic screen of overexpressed gene products. Several candidate targets have been identified and the prevelence of vaccine induced immunity has been assessed .
    This rapid screen to identify relevant antigenic targets will allow us to begin to dissect the mechanisms of tumor immunity induction and downregulation at the molecular level in cancer patients. More recently, we are using proteomics to identify proteins involved in pancreatic cancer development. We recently identified Annexin A2 as a molecule involved in metastases.

    The analysis of antitumor immune responses in patients enrolled on vaccine studies. The focus is on breast and pancreatic cancers. We are atttempting to identify in vitro correlates of in vivo antitumor immunity induced by vaccine strategies developed in the laboratory and currently under study in the clinics.
    view more

    Research Areas: immunology, cancer, anti-cancer drugs
  • Eugene Shenderov Laboratory

    Lab Website
    Principal Investigator:
    Eugene Shenderov, M.D., Ph.D.
    Oncology

    The Shenderov Lab focuses on the elucidation of the mechanisms of immune response and resistanc...e to immunotherapy in Prostate Cancer. This has led to clinical and basic research investigating the presumptive checkpoint inhibitor B7-H3.

    In pursuit of understanding biomarkers or resistance and response, and regulatory molecules of immune response, we utilize artificial intelligence, immunogenomics, and spatial proteomics and transcriptomics in the laboratory and at the bedside using clinical trial correlative samples.
    view more

    Research Areas: Cancer Immunotherapy, tumor antigens, prostate cancer, Immunogenomics, artificial intelligence, Spatialomics, B7-H3
  • Florin Selaru Lab

    Principal Investigator:
    Florin Selaru, M.D.
    Medicine
    Oncology

    Research interests in the Florin Selaru Lab comprise the molecular changes associated with the ...transition from inflammatory states in the GI tract (colon, stomach, biliary tree) to frank cancers. In addition, our current research—funded by the AGA, FAMRI and the Broad Foundation—works to further the understanding of cancer development and progression in the gastrointestinal tract. view more

    Research Areas: gastroenterology, cancer, inflammation, molecular biology
  • Follow the Leader: Specialized Cancer Cells Lead Collective Invasion (Ewald Lab)

    Lab Website
    Principal Investigator:
    Andrew Ewald, Ph.D.
    Cell Biology

    Research in the Ewald laboratory starts from a simple question: Which cells in a breast tumor a...re the most dangerous to the patient and most responsible for metastatic disease? To answer this question, we developed novel 3-D culture assays to allow real-time analysis of invasion. Our data reveal that K14+ cancer cells play a central role in metastatic disease and suggest that the development of clinical strategies targeting these cells will provide novel breast cancer treatments. view more

    Research Areas: breast cancer, cellular biology, molecular biology
  • Franck Housseau Lab

    Principal Investigator:
    Franck Housseau, Ph.D.
    Oncology

    The Franck Housseau Lab focuses on the role of the microbiome in colorectal tumorigenesis and o...n developing a better understanding of the tumor immune microenvironment. The lab is currently working to define the biomarkers of a pre-existing antitumor immune response in metastatic colorectal cancer to define a population of patients eligible for checkpoint blockade therapies. view more

    Research Areas: microbiology, tumor immunology, microbiome, colorectal cancer, cancer, colon cancer, tumor microenvironment, immunotherapy
  • GI Biomarkers Laboratory

    Principal Investigator:
    Stephen Meltzer, M.D.
    Medicine
    Oncology

    The GI Biomarkers Laboratory studies gastrointestinal cancer and pre-cancer biogenesis and biom...arkers. The lab is led by Dr. Stephen Meltzer, who is known for his research in the molecular pathobiology of gastrointestinal malignancy and premalignancy. Research in the lab has led to several groundbreaking genomic, epigenomic and bioinformatic studies of esophageal and colonic neoplasms, shifting the gastrointestinal research paradaigm toward genome-wide approaches. view more

    Research Areas: gastrointestinal system, translational research in Barrett’s esophagus-associated neoplastic progression, Molecular pathophysiology, biomarkers, cancer, epigenetics, genomics, bioinformatics, biogenesis
  • GI Early Detection Biomarkers Lab

    Principal Investigator:
    Stephen Meltzer, M.D.
    Medicine

    Dr. Meltzer is an internationally renowned leader in the molecular pathobiology of gastrointest...inal malignancy and premalignancy. He invented molecular methods to detect loss of heterozygosity in tiny biopsies, triggering an avalanche of research on precancerous lesions. He was the first to comprehensively study coding region microsatellite instability, leading to the identification of several important tumor suppressor genes. He performed several groundbreaking genomic, epigenomic and bioinformatic studies of esophageal and colonic neoplasms, shifting the GI research paradigm toward genome-wide approaches. He directed an ambitious nationwide validation study of DNA methylation-based biomarkers for the prediction of neoplastic progression in Barrett’s esophagus.

    Dr. Meltzer founded and led the Aerodigestive Cancer and Biomarker Interdisciplinary Programs at the University of Maryland, also becoming associate director for core sciences at that school’s Cancer Center. He currently holds an endowed professorship and is the director of GI biomarker research at Johns Hopkins.

    The laboratory group focuses its efforts on the molecular genetics of gastrointestinal cancers and premalignant lesions, as well as on translational research to improve early detection, prognostic evaluation, and treatment of these conditions. Below, some examples of this work are described.
    view more

    Research Areas: gastrointestinal cancer, gastrointestinal
  • Gilkes Lab

    Principal Investigator:
    Daniele Gilkes, Ph.D.
    Oncology

    Our lab is focused on determining the role of hypoxia in breast cancer metastasis. We are parti...cularly interested in the changes in the extracellular matrix that occur under hypoxic conditions and promote cancer cell migration. view more

    Research Areas: breast cancer, HIF-1, hypoxia, ECM
  • Grant (Xuguang) Tao Lab

    Principal Investigator:
    Grant Tao, M.D., Ph.D., M.S.
    Medicine

    Research in the Grant (Xuguang) Tao Lab explores environmental and occupational epidemiology to...pics, including workers' compensation and injuries, and nosocomial infections. We conduct research through clinical trials and systematic literature reviews, and also use cancer registry data and GIS applications in environmental epidemiological research. Our recent studies have explored topics such as the effectiveness of lumbar epidural steroid injections following lumbar surgery, the effect of physician-dispensed medication on workers' compensation claim outcomes and how the use of opioid and psychotropic medications for workers' compensation claims impacts lost work time. view more

    Research Areas: epidemiology, drug safety, cancer, nosocomial infections, GIS applications
  • Gregg Semenza Lab

    Principal Investigator:
    Gregg Semenza, M.D., Ph.D.
    Pediatrics

    The Gregg Semenza Lab studies the molecular mechanisms of oxygen homeostasis. We have cloned an...d characterized hypoxia-inducible factor 1 (HIF-1), a basic helix-loop-helix transcription factor.

    Current research investigates the role of HIF-1 in the pathophysiology of cancer, cerebral and myocardial ischemia, and chronic lung disease, which are the most common causes of mortality in the U.S.
    view more

    Research Areas: cancer, oxygen, lung disease, genomics, HIF-1, pathogenesis, myocardial ischemia
  • Gregory Kirk Lab

    Research in the Gregory Kirk Lab examines the natural history of viral infections — particularl...y HIV and hepatitis viruses — in the U.S. and globally. As part of the ALIVE (AIDS Linked to the Intravenous Experience) study, our research looks at a range of pathogenetic, clinical behavioral issues, with a special focus on non-AIDS-related outcomes of HIV, including cancer and liver and lung diseases. We use imaging and clinical, genetic, epigenetic and proteomic methods to identify and learn more about people at greatest risk for clinically relevant outcomes from HIV, hepatitis B and hepatitis C infections. Our long-term goal is to translate our findings into targeted interventions that help reduce the disease burden of these infections. view more

    Research Areas: global health, Hepatitis, Africa, AIDS, cancer, HIV, drugs, liver diseases
  • Head and Neck Cancer Clinical Trials and Tissue Bank

    The Johns Hopkins Head and Neck Cancer Tissue Bank enrolls patients and collects research speci...mens from Head and Neck Tumor patients, both cancerous and benign, with particular focus on Head and Neck Squamous Cell Cancer patients. It provides specimens to researchers both within the institution and outside. view more

    Research Areas: benign, malignant, cancer, tumor, head and neck tumors, Squamous cell carcinoma
  • Hsin-Chieh Yeh Lab

    Lab Website
    Principal Investigator:
    Hsin-Chieh Yeh, Ph.D.
    Medicine

    Work in the Hsin-Chieh Yeh Lab focuses on clinical trials and cohort studies of diabetes, obesi...ty and behavioral intervention, cancer and hypertension. Recent investigations have focused on novel risk factors and complications related to obesity and type 2 diabetes, particularly lung function, smoking and cancer. We recently co-led a randomized clinical trial of tailored dietary advice for consumption of dietary supplements to lower blood pressure and improve cardiovascular disease risk factors in hypertensive urban African Americans. view more

    Research Areas: epidemiology, African Americans, cancer, obesity, hypertension, diabetes, behavioral medicine
  • In-vivo Cellular and Molecular Imaging Center

    Lab Website

    The In-vivo Cellular and Molecular Imaging Center conducts multidisciplinary research on cellul...ar and molecular imaging related to cancer. We provide resources, such as consultation on biostatistics and bioinformatics and optical imaging and probe development, to understand and effectively treat cancer. Our molecular oncology experts consult on preclinical studies, use of human tissues, interpretation of data and molecular characterization of cells and tumor tissue. view more

    Research Areas: optical imaging, molecular characterization of tumor tissue, bioinformatics, molecular oncology, biostatistics, probe development, molecular characterization of cells, cancer imaging
  • J. Marie Hardwick Laboratory

    Lab Website

    Our research is focused on understanding the basic mechanisms of programmed cell death in disea...se pathogenesis. Billions of cells die per day in the human body. Like cell division and differentiation, cell death is also critical for normal development and maintenance of healthy tissues. Apoptosis and other forms of cell death are required for trimming excess, expired and damaged cells. Therefore, many genetically programmed cell suicide pathways have evolved to promote long-term survival of species from yeast to humans. Defective cell death programs cause disease states. Insufficient cell death underlies human cancer and autoimmune disease, while excessive cell death underlies human neurological disorders and aging. Of particular interest to our group are the mechanisms by which Bcl-2 family proteins and other factors regulate programmed cell death, particularly in the nervous system, in cancer and in virus infections. Interestingly, cell death regulators also regulate many other cellular processes prior to a death stimulus, including neuronal activity, mitochondrial dynamics and energetics. We study these unknown mechanisms.

    We have reported that many insults can trigger cells to activate a cellular death pathway (Nature, 361:739-742, 1993), that several viruses encode proteins to block attempted cell suicide (Proc. Natl. Acad. Sci. 94: 690-694, 1997), that cellular anti-death genes can alter the pathogenesis of virus infections (Nature Med. 5:832-835, 1999) and of genetic diseases (PNAS. 97:13312-7, 2000) reflective of many human disorders. We have shown that anti-apoptotic Bcl-2 family proteins can be converted into killer molecules (Science 278:1966-8, 1997), that Bcl-2 family proteins interact with regulators of caspases and regulators of cell cycle check point activation (Molecular Cell 6:31-40, 2000). In addition, Bcl-2 family proteins have normal physiological roles in regulating mitochondrial fission/fusion and mitochondrial energetics to facilitate neuronal activity in healthy brains.
    view more

    Research Areas: cell death
  • James Hamilton Lab

    Principal Investigator:
    James Hamilton, M.D.
    Medicine

    The main research interests of the James Hamilton Lab are the molecular pathogenesis of hepatoc...ellular carcinoma and the development of molecular markers to help diagnose and manage cancer of the liver. In addition, we are investigating biomarkers for early diagnosis, prognosis and response to various treatment modalities. Results of this study will provide a molecular classification of HCC and allow us to identify targets for chemoprevention and treatment. Specifically, we extract genomic DNA and total RNA from liver tissues and use this genetic material for methylation-specific PCR (MSP), cDNA microarray, microRNA microarray and genomic DNA methylation array experiments. view more

    Research Areas: Copper homeostasis, Wilson's disease, cancer, molecular genetics, Early detection biomarker discovery for hepatocellular carcinoma, genomics, pathogenesis, liver injury, liver diseases, regulation of lipid metabolism, hepatocellular carcinoma, Pathogenesis of Liver fibrosis and cancer
  • Joel Pomerantz Laboratory

    The Pomerantz Laboratory studies the molecular machinery used by cells to interpret extracellul...ar signals and transduce them to the nucleus to affect changes in gene expression. The accurate response to extracellular signals results in a cell's decision to proliferate, differentiate or die, and it's critical for normal development and physiology. The dysregulation of this machinery underlies the unwarranted expansion or destruction of cell numbers that occurs in human diseases like cancer, autoimmunity, hyperinflammatory states and neurodegenerative disease.

    Current studies in the lab focus on signaling pathways that are important in innate immunity, adaptive immunity and cancer, with particular focus on pathways that regulate the activity of the pleiotropic transcription factor NF-kB.
    view more

    Research Areas: immunology, neurodegenerative disorders, cancer, autoimmune, hyperinflammatory states, molecular biology
  • Jon Russell Lab

    The Jon Russell lab focuses on thyroid and parathyroid pathology as well as improving patient s...afety and education using healthcare technology. Additional focuses include utilizing new technology to advance on the techniques of minimally invasive neck surgery. Current and previous efforts include the development of mobile and web-based applications to educate physicians and patients, utilizing ultrasound for vocal cord imaging, understanding the nuances of advanced thyroid cancer, and exploring the role of scarless thyroid surgery in a North American population. view more

    Research Areas: patient satisfaction, thyroid cancer, perioperative information delivery, health outcomes, otolaryngology, postoperative care, endocrinology
  • Jun O. Liu Laboratory

    Lab Website

    The Jun O. Liu Laboratory tests small molecules to see if they react in our bodies to find pote...ntial drugs to treat disease. We employ high-throughput screening to identify modulators of various cellular processes and pathways that have been implicated in human diseases from cancer to autoimmune diseases. Once biologically active inhibitors are identified, they will serve both as probes of the biological processes of interest and as leads for the development of new drugs for treating human diseases. Among the biological processes of interest are cancer cell growth and apoptosis, angiogenesis, calcium-dependent signaling pathways, eukaryotic transcription and translation. view more

    Research Areas: cancer, autoimmune, eukaryotic cells, drugs, cellular signaling, pharmacology, calcium-dependent signaling pathways, molecular biology, angiogenesis
  • Kathleen Gabrielson Laboratory

    Principal Investigator:
    Kathleen Gabrielson, D.V.M., Ph.D.
    Molecular and Comparative Pathobiology

    Research in the Kathleen Gabrielson Laboratory focuses on the signal transduction of cardiovasc...ular toxicities in vitro, in cardiomyocyte culture and in vivo using rodent models. Specifically, the research focuses on understanding the mechanisms of various cancer therapies that induce cardiac toxicities.

    Currently, we are testing prevention strategies for these toxicities by studying the cardiac effects of the anthracycline doxorubicin (adriamycin) and the immunotherapeutic agent, Herceptin, anti-erbB2. We are focusing on the signal transduction pathways in the heart that are modulated by anti-erbB2 treatment, which in turn, worsens doxorubicin toxicity. Thus, understanding the mechanisms behind the combined toxicity of doxorubicin and anti-erbB2 will pave the way for the design of strategies to reduce toxicity, identify patients at risk and potentially allow higher levels of this effective combination therapy to be used with an improved long-term survival in patients.
    view more

    Research Areas: cardiovascular toxicity, cancer, pathology, signal transduction
  • Kathryn Carson Lab

    Principal Investigator:
    Kathryn Carson, Sc.M.
    Medicine

    The Kathryn Carson Lab investigates ways to improve medical research, particularly in the areas... of brain and thyroid cancer, Alzheimer’s disease, atherosclerosis, hypertension, HIV and lupus. Our team seeks to help researchers optimize their studies through better study design, protocol and grant writing, data cleaning and analysis, and publication writing. We work with investigators from a wide range of departments through the Johns Hopkins Institute for Clinical and Translational Research. view more

    Research Areas: epidemiology, lupus, research methods, data analysis, cancer, hypertension, clinical trials, HIV, biostatistics, Alzheimer's disease
  1. 1
  2. 2
Create lab profile
Edit lab profile
back to top button